Recreational Futsal for Controlled Hypertension
HyperFut
Recreational Futsal as a Coadjuvant in Male Adults With Controlled Hypertension - a Randomized Controlled Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
Arterial hypertension (HT) was the leading global contributor for premature deaths in 2015. Its treatment includes medication and lifestyle changes, namely diet and regular exercise, which has shown to have an inverse relationship with arterial HT. Recreational soccer (RS) has proven to be a non-pharmacological treatment for several chronic conditions, including arterial HT, with meaningful decreases on blood pressure (BP). Recreation futsal (RF) is expected to elicit comparable BP changes to RS considering that it imposes similar physical and physiological demands. However, the effects of RF on BP and other cardiovascular markers have not been previously investigated in participants only with controlled arterial HT. Furthermore, acute BP changes and double product elicited by this exercise modality were never described. Therefore, the main purpose of this study is to assess if RF is an effective coadjuvant intervention for BP control in adults with controlled arterial HT. Secondary purposes are: i) to determine the impact of RF on other cardiovascular markers; ii) to describe the acute BP changes and the double product elicited by RF; and iii) to assess the impact of 1 month of detraining on BP and other cardiovascular markers (4 months).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 17, 2021
CompletedFirst Submitted
Initial submission to the registry
December 20, 2021
CompletedFirst Posted
Study publicly available on registry
January 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2022
CompletedFebruary 6, 2023
February 1, 2023
12 months
December 20, 2021
February 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Between-groups differences in systolic blood pressure
Casual (resting) measures of systolic blood pressure (mmHg) will be measured in triplicate over the brachial artery of the non-dominant arm after 5 minutes of quiet rest, with 1 minute of recovery between each measure, using an automated oscillometric sphygmomanometer.
3 months
Between-groups differences in diastolic blood pressure
Casual (resting) measures of diastolic blood pressure (mmHg) will be measured in triplicate over the brachial artery of the non-dominant arm after 5 minutes of quiet rest, with 1 minute of recovery between each measure, using an automated oscillometric sphygmomanometer.
3 months
Secondary Outcomes (38)
Between-groups differences in systolic blood pressure
4 months
Between-groups differences in diastolic blood pressure
4 months
Between-groups differences in mean blood pressure
3 months
Between-groups differences in mean blood pressure
4 months
Between-groups differences in total cholesterol
3 months
- +33 more secondary outcomes
Study Arms (2)
Standard care
NO INTERVENTIONParticipants will continue with standard care provided by the family physician.
Recreational Futsal, plus standard care
EXPERIMENTALParticipants will participate in 2-3 weekly one hour sessions of Recreational Futsal, during 3 months, while maintaining standard care provided by the family physician.
Interventions
Participants will participate in 2-3 weekly one hour sessions of Recreational Futsal, during 3 months, while maintaining standard care provided by the family physician.
Eligibility Criteria
You may qualify if:
- Medicated controlled hypertension, with habitual SBP below 140 mmHg and DBP below 90 mmHg;
- Males with 35-60 years;
- Not being engaged in regular and supervised physical exercise in the last 6 months;
- Medical clearance;
- Vaccinated against SARS-COV-2.
You may not qualify if:
- Cardiovascular disease (heart failure), cerebrovascular disease, advanced retinopathy or kidney failure;
- Resistant hypertension;
- History of cardiovascular event.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Institute of Maialead
- University of Southern Denmarkcollaborator
Study Sites (1)
University of Maia
Maia, Portugal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susana Póvoas, PhD
University of Maia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Blood analysis, maximum oxygen consumption and DEXA scans will have blinded outcome assessors.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associated Professor
Study Record Dates
First Submitted
December 20, 2021
First Posted
January 11, 2022
Study Start
November 17, 2021
Primary Completion
October 31, 2022
Study Completion
December 19, 2022
Last Updated
February 6, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share